Azra H. Ligon

Chief, Clinical Cytogenetics and CEO, ABMGG · Brigham & Women’s Hospital · company speakers →

Dr. Ligon has been a Clinical Cytogeneticist at Brigham & Women’s Hospital (BWH) in Boston since 1999. Her clinical interests include the cytogenetics of primary CNS tumors and translation of research tools to clinical use. Beginning in 2003, Dr. Ligon served as the Program Director for the BWH Clinical Cytogenetics Fellowship and then later as the Associate Program Director for the BWH LGG Fellowship. She has served on ACMG Committees, on the ABMGG Board of Directors, and on the ACGME Review Committee for Medical Genetics and Genomics. In 2025 she assumed the role of CEO of the American Board of Medical Genetics and Genomics.

Is this you? Claim this profile →